Information Journal Paper
APA:
Copy. (2018). COMPARATIVE EFFECTIVENESS OF SWITCHING PAROXETINE FORMULATION FOR TREATMENT OF MAJOR DEPRESSIVE DISORDER: AN OPEN-LABEL MULTICENTER STUDY. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 14(-), 0-0. SID. https://sid.ir/paper/742395/en
Vancouver:
Copy. COMPARATIVE EFFECTIVENESS OF SWITCHING PAROXETINE FORMULATION FOR TREATMENT OF MAJOR DEPRESSIVE DISORDER: AN OPEN-LABEL MULTICENTER STUDY. NEUROPSYCHIATRIC DISEASE AND TREATMENT[Internet]. 2018;14(-):0-0. Available from: https://sid.ir/paper/742395/en
IEEE:
Copy, “COMPARATIVE EFFECTIVENESS OF SWITCHING PAROXETINE FORMULATION FOR TREATMENT OF MAJOR DEPRESSIVE DISORDER: AN OPEN-LABEL MULTICENTER STUDY,” NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol. 14, no. -, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/742395/en